Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A. Hanley

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Annals of Internal Medicine|March 7, 2007
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trialSusan L Greenspan, Henry G Bone, Mark P Ettinger, et al.
Nutrients|October 1, 2016
The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled TrialMichelle C Mann, Derek V Exner, Brenda R Hemmelgarn, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 10, 2010
Health-related quality of life in Canadian adolescents and young adults: normative data using the SF-36Wilma M Hopman, Claudie Berger, Lawrence Joseph, et al.
Menopause (New York, N.Y.)|June 18, 2010
Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture riskLisa Langsetmo, Suzanne Morin, Christopher S Kovacs, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 12, 2013
Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosisE Michael Lewiecki, Paul D Miller, Steve T Harris, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 14, 2010
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis CanadaDavid A Hanley, Ann Cranney, Glenville Jones, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 8, 2002
Is there regional variation in the SF-36 scores of Canadian adults?Wilma M Hopman, Claudie Berger, Lawrence Joseph, et al.
The American Journal of Medicine|September 4, 2012
Interventions to increase osteoporosis treatment in patients with 'incidentally' detected vertebral fracturesSumit R Majumdar, Finlay A McAlister, Jeffrey A Johnson, et al.
Arthritis and Rheumatism|January 30, 2009
Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trialDonald W Morrish, Lauren A Beaupre, Neil R Bell, et al.
Archives of Internal Medicine|October 24, 2007
Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trialSumit R Majumdar, Lauren A Beaupre, Charles H Harley, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Annals of Internal Medicine|March 7, 2007
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trialSusan L Greenspan, Henry G Bone, Mark P Ettinger, et al.
Nutrients|October 1, 2016
The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled TrialMichelle C Mann, Derek V Exner, Brenda R Hemmelgarn, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 10, 2010
Health-related quality of life in Canadian adolescents and young adults: normative data using the SF-36Wilma M Hopman, Claudie Berger, Lawrence Joseph, et al.
Menopause (New York, N.Y.)|June 18, 2010
Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture riskLisa Langsetmo, Suzanne Morin, Christopher S Kovacs, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 12, 2013
Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosisE Michael Lewiecki, Paul D Miller, Steve T Harris, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 14, 2010
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis CanadaDavid A Hanley, Ann Cranney, Glenville Jones, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 8, 2002
Is there regional variation in the SF-36 scores of Canadian adults?Wilma M Hopman, Claudie Berger, Lawrence Joseph, et al.
The American Journal of Medicine|September 4, 2012
Interventions to increase osteoporosis treatment in patients with 'incidentally' detected vertebral fracturesSumit R Majumdar, Finlay A McAlister, Jeffrey A Johnson, et al.
Arthritis and Rheumatism|January 30, 2009
Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trialDonald W Morrish, Lauren A Beaupre, Neil R Bell, et al.
Archives of Internal Medicine|October 24, 2007
Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trialSumit R Majumdar, Lauren A Beaupre, Charles H Harley, et al.
Pageof 18